Experience Matters.

Lawrence Blatt

Non-Executive Director

Iain D. Dukes

Non-Executive Director

Ron Hunt

Managing Director, New Leaf Venture Partners

Richard N. Kender

Non-Executive Director

Chau Q. Khuong

Private Equity Partner, OrbiMed

Nanna Lüneborg

Partner, Novo Holdings

Dr. Ken Powell

Chairman

Alex C. Sapir

Chief Executive Officer

Raphaël Wisniewski

Partner, Andera Partners

Dr. Stuart Cockerill

Chief Scientific Officer, Founder

Spearheaded the GSK erbB2 Oncology Project Team that discovered Tykerb™ for metastatic breast cancer.

Dr. Rachel Harland

Head of Preclinical Development

Built value for two top-tier biotech companies via pivotal drug development strategies.

Dr. Seth Hetherington

Chief Medical Officer

Word class pediatric infectious disease physician – led clinical development of multiple therapeutic vaccines at Genocea Biosciences.

Dr. Eddy Littler

Chief Operating Officer

Led the identification and development of OlysioTM for chronic hepatitis C virus.

Dr. Neil Mathews

Project Director, Founder

Led deal-critical Hepatitis C project at Arrow Therapeutics prior to acquisition by AstraZeneca.

Alan A. Musso

Chief Financial Officer

Secured $150M financing and prepared Peloton Therapeutics for IPO — laying groundwork for Merck & Co. acquisition.

Alex C. Sapir

Chief Executive Officer

Grew small biotech start-up with upside to 150-person, publicly-traded company with approved, marketed product.

Dr. Elaine Thomas

Head of Virology

Advanced from Harvard Medical School post-doctoral fellowship to lead multiple preclinical & clinical virology studies.